Bas D Koster

6PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jul 20, 2022
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.

Kim M van Pul, Jessica C L Notohardjo, Marieke F Fransen

|Feb 01, 2020
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma.

Bas D Koster, Tamarah D de Jong, Mari F C M van den Hout

|Mar 29, 2019
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Bas D Koster, Saskia J A M Santegoets, Jorien Harting

|Mar 11, 2019
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Bas D Koster, Saskia J A M Santegoets, Jorien Harting

Pageof 1

Frequent Collaborators

3 joint publications

Tanja D de Gruijl

3 joint publications

Alfons J M van den Eertwegh

2 joint publications

Saskia J A M Santegoets

2 joint publications

Erik Hooijberg